Delivery Order 36C25726D0022-36C25726N0093
- Not listed
- The Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a $1.2M firm fixed-price delivery order to Optum Infusion Services 308, LLC for pharmacy compounding services focused on oncology drugs at the Dallas VA facility in Dallas, Texas. The contract, awarded on November 1, 2025, runs through October 31, 2030, and represents a continuation of specialized pharmaceutical services supporting cancer treatment for veteran patients. This delivery order was issued without a...
- Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, received a $115,000 delivery order from Veterans Integrated Service Network (VISN) 17 for pharmacy compounding services to be performed in Amarillo, Texas. The task order, issued under the master contract 336C25720D0073 and utilizing the Federal Acquisition Regulation clause 52.217-8, carries a performance period from June 1, 2025 through October 31, 2025. The contract employs firm fixed-price pricing and was awarded...
- The Department of Veterans Affairs, Veterans Integrated Service Network 16, awarded a $300,000 delivery order for hazardous compounding services to Optum Infusion Services 308, LLC, with a completion date of September 30, 2026. The contract, awarded on October 30, 2025, operates under a firm fixed-price structure with no set-aside designation and will be performed in Chandler, Arizona. Optum Infusion Services 308, LLC is a subsidiary of UnitedHealth Group Incorporated, a major healthcare...
- This is a federal contract award for chemo compounding services, valued at $1,071,930.52, awarded to Optum Infusion Services 308, LLC by the Veterans Integrated Service Network 2, a civilian agency. The contract is a delivery order with a firm-fixed price type and an ultimate completion date of September 30, 2026. Optum Infusion Services 308, LLC is a subsidiary of UnitedHealth Group Incorporated, a large, diversified healthcare company that provides a range of services to federal government...
- This is a definitive, firm-fixed-price contract awarded by the Department of Veterans Affairs (VA) to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract, valued at $4,519,085.96, is for sterile hazardous compounding services to be provided to the VA's Veterans Integrated Service Network (VISN) 16, which covers facilities in Arkansas. The contract has a period of performance through December 25, 2024 and was not set aside for any particular business type. Optum...
- This federal contract award, valued at $74,885.03, was issued by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The contract is a firm fixed-price purchase order for the "Ratification of Two UACs", with an ultimate completion date of November 30, 2024. Optum Pharmacy 801, Inc. is a specialized pharmacy that provides compounded chemotherapy agents, hazardous...
- This federal contract award is for compounded chemotherapy services provided to the U.S. Department of Veterans Affairs (VA) through Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated. The Indefinite Delivery, Indefinite Quantity (IDIQ) contract has a ceiling value of $100,000.00 and a period of performance through September 30, 2026. The contract is a firm-fixed-price delivery order and does not have a set-aside designation, indicating it was awarded through full and open...
- This is a $55,205.54 firm fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, to provide custom-dosed chemotherapy IV medications for the VA Baltimore Medical Center. The contract has a performance period through June 30, 2025. This requirement was competed on a full and open basis, without any set-aside designations. Optum Pharmacy 801, Inc., operating as Avella Specialty Pharmacy, has...
- This federal contract award is for a delivery order under the "Ordering Period 4 - Sterile Compounding" contract, with a ceiling value of $100,000.00. The contract was awarded to Optum Pharmacy 801, Inc., a subsidiary of UnitedHealth Group Incorporated, on October 2, 2025. The contract is a firm fixed-price delivery order awarded by the Veterans Integrated Service Network (VISN) 16, which is part of the U.S. Department of Veterans Affairs (VA). The contract involves the provision of...
- This federal contract award, valued at $20,000.00, is for Pharmacy Compound Drugs Option Year 4 Order to Optum Pharmacy 601, LLC, a subsidiary of UnitedHealth Group Incorporated. The contract was awarded by the Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 2 (VISN 2), to provide pharmacy compounding services, including sterile hazardous drug compounding, emergency compounding, and chemotherapy IV medications. The contract has a firm fixed-price pricing...
- 36C25726D0022Indefinite Delivery Contract
- 36C25726D0022-36C25726N0093Delivery Order
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a $100,000 firm fixed-price delivery order to Optum Infusion Services 308, LLC for pharmacy compounding services supporting oncology medications at the Amarillo VA medical facility in Texas. The contract is effective through October 31, 2026, and was awarded on November 1, 2025, with no set-aside designation applied. Optum Infusion Services 308, LLC operates as a subsidiary of UnitedHealth Group Incorporated, a diversified healthcare organization headquartered in Minnetonka, Minnesota, that provides extensive pharmaceutical and healthcare services to federal agencies through multiple specialized divisions. This delivery order represents a continuation of specialized pharmaceutical services that UnitedHealth Group subsidiaries have provided to the VA under larger contract vehicles. The parent company maintains multiple federal Indefinite Delivery contracts with the VA and other agencies, including a $3.3 billion Medical Disability Examination IDIQ and various pharmacy-related agreements. The compounding of oncology medications is a critical clinical function that supports cancer treatment programs within the VA healthcare system, enabling the provision of customized pharmaceutical preparations tailored to individual patient needs at the point of care in Amarillo.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $100.0k | 10/27/25 |